UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis

International journal for equity in health, 2013-01, Vol.12 (1), p.9-9

2013

Link zum Volltext

Verfügbarkeit prüfen

Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Quality of life research, 2017-05, Vol.26 (5), p.1187-1195

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.2892-2900

2014

Link zum Volltext

Verfügbarkeit prüfen

Community-based health insurance programmes and the National Health Insurance Scheme of Nigeria: challenges to uptake and integration

International journal for equity in health, 2014-02, Vol.13 (1), p.20-20

Odeyemi, Isaac A O

2014

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.2901-2912

2014

Link zum Volltext

Verfügbarkeit prüfen

Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data

Current medical research and opinion, 2015-01, Vol.31 (1), p.43-50

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of the overactive bladder on health‐related utility and quality of life

BJU international, 2006-06, Vol.97 (6), p.1267-1272

2006

Link zum Volltext

Verfügbarkeit prüfen

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

Clinical drug investigation, 2015-02, Vol.35 (2), p.83-93

2015

Link zum Volltext

Verfügbarkeit prüfen

“Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making

Health policy (Amsterdam), 2006-08, Vol.77 (3), p.352-367

2006

Link zum Volltext

Verfügbarkeit prüfen

Health economics and outcomes research within drug development Challenges and opportunities for reimbursement and market access within biopharma research

Drug discovery today, 2012-06, Vol.17 (11-12), p.615-622

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

European urology, 2006-03, Vol.49 (3), p.519-527

2006

Link zum Volltext

Verfügbarkeit prüfen

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study

Journal of health economics and outcomes research (Online), 2016-08, Vol.4 (2), p.127-140

2016

Link zum Volltext

Verfügbarkeit prüfen

De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections

Journal of medical economics, 2013-11, Vol.16 (11), p.1344-1356

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

Current medical research and opinion, 2009-01, Vol.25 (1), p.239-250

2009

Link zum Volltext

Verfügbarkeit prüfen

The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?

ClinicoEconomics and outcomes research, 2013-01, Vol.5 (default), p.109-118

2013

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

Value in health, 2015-09, Vol.18 (6), p.783-790

2015

Link zum Volltext

Verfügbarkeit prüfen

Health economics and outcomes research within drug development

Drug discovery today, 2012-06, Vol.17 (11-12), p.615-622

2012

Link zum Volltext

Verfügbarkeit prüfen

Modelling the economic impact of recombinant activated Factor VII and activated prothrombin-complex concentrate in the treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX at a comprehensive care centre in the UK

Journal of medical economics, 2002, Vol.5 (1-4), p.51-64

2002

Link zum Volltext

Verfügbarkeit prüfen

An economic evaluation of the impact of the privatisation policy on animal health delivery services in africa: a case study of zimbabwe

Odeyemi, Isaac A. O

1999

Link zum Volltext
ProQuest

Magnetospheric chaos and dynamical complexity response during storm time disturbance

Nonlinear processes in geophysics, 2021-05, Vol.28 (2), p.257-270

2021

Link zum Volltext

Verfügbarkeit prüfen

Morphology of GPS and DPS TEC over an equatorial station: validation of IRI and NeQuick 2 models

Annales geophysicae (1988), 2018-10, Vol.36 (5), p.1457-1469

2018

Link zum Volltext

Verfügbarkeit prüfen

Digital Technologies, Online Engagement and Parliament-Citizen Relations in Nigeria and South Africa

Perspectives on the Legislature and the Prospects of Accountability in Nigeria and South Africa, p.217-232

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Humans
(13)
Life Sciences & Biomedicine
(12)
Cost-Benefit Analysis
(5)
Quality Of Life
(5)
United Kingdom
(5)
Aged
(4)
Male
(4)
Middle Aged
(4)
Adult
(3)
Biological And Medical Sciences
(3)
Decision Support Techniques
(3)
Developing Countries
(3)
Health Care Sciences & Services
(3)
Health Insurance
(3)
Medical Sciences
(3)
Pharmacology & Pharmacy
(3)
Public, Environmental & Occupational Health
(3)
Acetanilides - Economics
(2)
Acetanilides - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis

Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison

Community-based health insurance programmes and the National Health Insurance Scheme of Nigeria: challenges to uptake and integration

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection

Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data

The impact of the overactive bladder on health‐related utility and quality of life

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

“Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making

Health economics and outcomes research within drug development Challenges and opportunities for reimbursement and market access within biopharma research

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study

De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections

Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?

Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

Health economics and outcomes research within drug development

Modelling the economic impact of recombinant activated Factor VII and activated prothrombin-complex concentrate in the treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX at a comprehensive care centre in the UK

An economic evaluation of the impact of the privatisation policy on animal health delivery services in africa: a case study of zimbabwe

Magnetospheric chaos and dynamical complexity response during storm time disturbance

Morphology of GPS and DPS TEC over an equatorial station: validation of IRI and NeQuick 2 models

Digital Technologies, Online Engagement and Parliament-Citizen Relations in Nigeria and South Africa

Suchergebnisse filtern